Endpoints News· @endpts · X·· 2 天前AI 评分27
AI 导读
由 Jennifer Doudna 联合创立的 Azalea Therapeutics，利用基因编辑在体内制造 CAR-T 细胞。它为何入选 Endpoints 11：https://endpoints.news/endpoints-11-2026-winner-azalea-melds-gene-editing-and-car-t/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content= 今天在我们的免费线上活动中，通过独家采访聆听获奖者的分享。
正文
Azalea Therapeutics, co-founded by Jennifer Doudna, uses gene editing to make CAR-T cells inside the body. Why it made the Endpoints 11: https://endpoints.news/endpoints-11-2026-winner-azalea-melds-gene-editing-and-car-t/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial&utm_content=
Hear from honorees during exclusive interviews at our free virtual event today.
来源：Endpoints News · x.com